Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ali Zarrabi

Showing results (221-230 of 302) with videos related to

Pageof 31
Sort By:
Cellular Signalling|December 6, 2020
Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediatorsMilad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
Expert Reviews in Molecular Medicine|September 29, 2021
MicroRNAs regulating SOX2 in cancer progression and therapy responseSepideh Mirzaei, Hamidreza Saebfar, Mohammad Hossein Gholami, et al.
Life Sciences|May 27, 2021
Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospectsMilad Ashrafizadeh, Sepideh Mirzaei, Kiavash Hushmandi, et al.
Biosensors & Bioelectronics|January 29, 2023
Biosensor integrated brain-on-a-chip platforms: Progress and prospects in clinical translationBerivan Cecen, Ecem Saygili, Iman Zare, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 22, 2022
AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigationMaliheh Entezari, Danial Hashemi, Afshin Taheriazam, et al.
Cancer Letters|March 26, 2021
Long non-coding RNAs in the doxorubicin resistance of cancer cellsSaeed Ashrafizaveh, Milad Ashrafizadeh, Ali Zarrabi, et al.
Cells|December 24, 2021
Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer TherapySepideh Mirzaei, Mohammad Hossein Gholami, Hui Li Ang, et al.
Current Molecular Medicine|January 5, 2021
Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive ReviewReza Sharafati-Chaleshtori, Ali Nickdasti, Erfan Mortezapour, et al.
European Journal of Pharmacology|July 16, 2021
The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targetsSepideh Mirzaei, Asal Jalal Abadi, Mohammad Hossein Gholami, et al.
Journal of Cellular Physiology|September 27, 2021
Long noncoding RNAs: A novel insight in the leukemogenesis and drug resistance in acute myeloid leukemiaAnuradha Kirtonia, Milad Ashrafizadeh, Ali Zarrabi, et al.
Pageof 31

Showing results (221-230 of 302) with videos related to

Sort By:
Pageof 31
Cellular Signalling|December 6, 2020
Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediatorsMilad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
Expert Reviews in Molecular Medicine|September 29, 2021
MicroRNAs regulating SOX2 in cancer progression and therapy responseSepideh Mirzaei, Hamidreza Saebfar, Mohammad Hossein Gholami, et al.
Life Sciences|May 27, 2021
Therapeutic potential of AMPK signaling targeting in lung cancer: Advances, challenges and future prospectsMilad Ashrafizadeh, Sepideh Mirzaei, Kiavash Hushmandi, et al.
Biosensors & Bioelectronics|January 29, 2023
Biosensor integrated brain-on-a-chip platforms: Progress and prospects in clinical translationBerivan Cecen, Ecem Saygili, Iman Zare, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 22, 2022
AMPK signaling in diabetes mellitus, insulin resistance and diabetic complications: A pre-clinical and clinical investigationMaliheh Entezari, Danial Hashemi, Afshin Taheriazam, et al.
Cancer Letters|March 26, 2021
Long non-coding RNAs in the doxorubicin resistance of cancer cellsSaeed Ashrafizaveh, Milad Ashrafizadeh, Ali Zarrabi, et al.
Cells|December 24, 2021
Pre-Clinical and Clinical Applications of Small Interfering RNAs (siRNA) and Co-Delivery Systems for Pancreatic Cancer TherapySepideh Mirzaei, Mohammad Hossein Gholami, Hui Li Ang, et al.
Current Molecular Medicine|January 5, 2021
Artemisia Species as a New Candidate for Diabetes Therapy: A Comprehensive ReviewReza Sharafati-Chaleshtori, Ali Nickdasti, Erfan Mortezapour, et al.
European Journal of Pharmacology|July 16, 2021
The involvement of epithelial-to-mesenchymal transition in doxorubicin resistance: Possible molecular targetsSepideh Mirzaei, Asal Jalal Abadi, Mohammad Hossein Gholami, et al.
Journal of Cellular Physiology|September 27, 2021
Long noncoding RNAs: A novel insight in the leukemogenesis and drug resistance in acute myeloid leukemiaAnuradha Kirtonia, Milad Ashrafizadeh, Ali Zarrabi, et al.
Pageof 31